|
|
|
February 27, 2017 WHO publishes list of bacteria for which new antibiotics are urgently needed. World Health Organization, February 27, 2017.
The WHO’s “priority pathogens” list was drawn up in a bid to guide and promote research and development (R&D) of new antibiotics, as part of
February 27, 2017 Deadly, Drug-Resistant "Superbugs" Pose Huge Threat, WHO Says. The New York Times, February 27, 2017.
“We are fast running out of treatment options,” said Dr. Marie-Paule Kieny, the W.H.O. assistant director general who released the [priority pathogen
April 20, 2017 NAEJA-RGM Pharmaceuticals Inc.: A Re-Awakening of Canada's Best-Kept Secret for Pharmaceutical Research. Click here to read our Press Release
March 10, 2017 Deadly fungal infection that doctors have been fearing now reported in U.S Washington Post, March 10, 2017. Nearly three dozen people in the United States have been diagnosed with a deadly and highly drug-resistant fungal infection since federal health officials first warned clinicians last June to be on the lookout for the emerging pathogen that has been spreading around the world. Some strains are resistant to all three major classes of antifungal drugs… February 28, 2017 The drug-resistant bacteria that pose the greatest health threats. Nature News, February 28, 2017. Antibiotic resistance kills an estimated 700,000 people each year worldwide, and some experts predict that number to reach 10 million by 2050 if efforts are not made to curtail resistance or develop new antibiotics. Despite an urgent need for these drugs, the once-robust development pipeline for antibiotics now produces little more than a trickle of compounds… February 27, 2017 WHO's "priority pathogens" list highlights urgent need for new drugs. CBC News, February 27, 2017. The World Health Organization has released its first list of the world’s most dangerous superbugs – 12 families of bacterial supervillains considered the most serious threats to human health. The WHO calls it a list of “priority pathogens”… February 27, 2017 WHO publishes list of bacteria for which new antibiotics are urgently needed. World Health Organization, February 27, 2017. The WHO’s “priority pathogens” list was drawn up in a bid to guide and promote research and development (R&D) of new antibiotics, as part of WHO’s efforts to address growing global resistance to antimicrobial medicines. The list highlights in particular the threat of gram-negative bacteria that are resistant to multiple antibiotics. These bacteria have built-in abilities to find new ways to resist treatment and can pass along genetic material that allows other bacteria to become drug-resistant as well… February 27, 2017 Deadly, Drug-Resistant "Superbugs" Pose Huge Threat, WHO Says. The New York Times, February 27, 2017. “We are fast running out of treatment options,” said Dr. Marie-Paule Kieny, the W.H.O. assistant director general who released the [priority pathogen] list. “If we leave it to market forces alone, the new antibiotics we most urgently need are not going to be developed in time.”… February 22, 2017 "Alarming" superbugs a risk to people, animals, and food, EU warns. The Globe & Mail, February 22, 2017. “Antimicrobial resistance is an alarming threat putting human and animal health in danger,” said Vytenis Andriukaitis, the EU’s health and food safety commissioner. “We have put substantial efforts to stop its rise, but this is not enough. We must be quicker, stronger and act on several fronts.”… February 18, 2017 Space-X is sending a drug resistant superbug to space. Quirks & Quarks, February 18, 2017. The pathogen known as MRSA is lethal, and highly resistant to known antibiotics. Now it’s being sent into space by a nano-biotechnology company using a Space-X rocket. Once it reaches the International Space Station, the pathogen will be subject to experiments designed to test the hypothesis that microgravity will accelerate the bug’s mutation… February 1, 2017 Report: Antibiotic Resistance Rising in Europe Center for Infectious Disease Research and Policy (CIDRAP News) January 18, 2017 We Will Miss Antibiotics When They're Gone. The New York Times, January 18, 2017. The Centers for Disease Control and Prevention released a disturbing report about the death of an elderly woman in Washoe County, Nevada. What killed her wasn’t heart disease, cancer, or pneumonia. What killed her were bacteria that were resistant to every antibiotic doctors could throw at them… September 7, 2016 Ontario scientist thinks old drugs could become our new antibiotics. CBC News, September 7, 2016. As the world loses its upper hand in the antibiotic arms race, it raises the spectre of untreatable infections resulting from routine surgeries. But a Canadian scientist has discovered a surprising source of potential antibiotic options… August 29, 2016 Bacteria with worrisome superbug genes found in U.S. Thomson Reuters, August 29, 2016. New Jersey researchers said on Monday they had identified perhaps the first strain of E. Coli bacteria in the United States with mobile genes that make it resistant to two types of antibiotics now considered last-line defenses against superbugs… May 27, 2016 Health officials concerned over spread of resistance to last-resort antibiotic. CBC News, May 27, 2016. British Prime Minister David Cameron urged G7 leaders meeting in Japan to do more to fight superbugs. His comments followed the first U.S. report of a patient infected with bacteria resistant to a last-resort antibiotic called colistin… January 21, 2016 Superbug fight unites drug industry. CBC News, January 21, 2016. More than 80 international drug and biotech firms urged governments to work with them to combat drug resistant superbugs which could kill tens of millions of people within decades unless progress is made and new antibiotics found. November 27, 2013 NAEJA Pharmaceutical Receives "Company of the Year" Award from Alberta Life Sciences Community Award by BioAlberta, an industry association that supports the province's growing community of biotechnology. EDMONTON, Nov. 27, 2013 /CNW/ - NAEJA Pharmaceutical, Inc. was recognized with the "Company of the Year" award by BioAlberta, an industry association that supports the province's growing community of biotechnology, environmental science, medical devices, agriculture, bio-informatics and natural health product companies. The award was presented to NAEJA at the 14th Annual General Meeting and Awards Gala, an event that was attended by approximately 150 industry leaders and government dignitaries. This award recognizes life sciences companies that show significant achievement within Alberta's marketplace and business community through strong performance or a leadership role. "We are honored to receive this prestigious award from BioAlberta, which serves as a testimony to the many contributions that NAEJA has made to the Alberta and Canadian biotechnology industry over the years. In collaboration with global strategic partners both in industry as well as academia, our team of scientists has discovered and developed many life-saving drugs that are either in various stages of development or are in clinical use" remarked Christopher G. Micetich, chief executive officer of NAEJA Pharmaceutical. "NAEJA has also fostered an environment of scientific excellence and has been a major employer of graduates from universities across Canada and globally. We look forward to continuing to make tangible contributions to the life sciences community here in Alberta and worldwide." About NAEJA NAEJA is a privately owned pharmaceutical drug discovery and development company headquartered in Edmonton, Alberta, Canada. The company was established in 1987 (earlier known as SynPhar laboratories Inc.) and employs over 50 scientists, of whom 90% hold Ph.D. degrees. NAEJA has an extensive track record of drug discovery and development in many disease areas including infectious diseases, inflammation, cancer, cardiovascular disease and diseases of the central nervous system. NAEJA collaborates with major pharmaceutical and biotechnology companies worldwide. For more information on the company, please visit www.NAEJA.com. |
|
April 20, 2017 NAEJA-RGM Pharmaceuticals Inc.: A Re-Awakening of Canada's Best-Kept Secret for Pharmaceutical Research. Click here to read our Press Release
March 10, 2017 Deadly fungal infection that doctors have been fearing now reported in U.S Washington Post, March 10, 2017.
Nearly three dozen people in the United States have been diagnosed with a deadly and highly drug-resistant fungal infection since federal health officials first
|
Copyright © 2024 NAEJA-RGM | Privacy Policy and Terms of Use
